6 July 2022 in Journal of Clinical Apheresis
6 January 2021 in Journal of Cosmetic Dermatology
1 September 2026 in Journal of Clinical and Analytical Medicine
Aim IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide and shows highly heterogeneous clinical progression. Although preserved renal function at diagnosis is generally considered a favorable prognostic feature, a subset of patients still develops progressive kidney function decline. Determinants of early decline in patients with preserved renal function remain incompletely understood. This study aimed to evaluate clinical, laboratory, and histopathological predictors of rapid kidney function decline in adult patients with IgAN and preserved renal function at diagnosis. Methods This retrospective single-center cohort study included adult patients with biopsy-proven IgAN and baseline estimated glomerular filtration rate (eGFR) > 50 mL/min/1.73 m². Annual eGFR change was calculated from baseline and follow-up values, and rapid decline was defined as an annual loss exceeding 3 mL/min/1.73 m². Demographic characteristics, laboratory parameters, treatment data, and Oxford MEST-C histopathological features were analyzed. Multivariable logistic regression was performed to identify predictors of rapid kidney function decline. Results Fifty-seven patients were included, with a median follow-up of 42 months. Sixteen patients (28.1%) experienced rapid kidney function decline. Diabetes mellitus (DM) was significantly more frequent in patients with rapid decline and remained an independent predictor in multivariable analysis. A higher percentage of global glomerulosclerosis was also independently associated with rapid decline. Baseline proteinuria and Oxford MEST-C features were not significantly associated with early eGFR loss. Conclusion DM and the degree of global glomerulosclerosis independently predicted early decline in kidney function in patients with IgAN and preserved renal function.